Virus Research At Serbia's Institute of Virology

A laboratory technician injects Influenza A (H1N1) virus into a tray of embryonated hens' eggs during vaccine research work at the Torlak Institute of Virology in Belgrade, Serbia, on Tuesday, March 3, 2020. Coronavirus death rates, estimated at around 2%, are higher than the 0.1% for seasonal flu, another lung infection, but far lower than those from severe acute respiratory syndrome, or SARS, the related virus that killed about 9.6% of some 8,000 people infected. Photographer: Oliver Bunic/Bloomberg via Getty Images
A laboratory technician injects Influenza A (H1N1) virus into a tray of embryonated hens' eggs during vaccine research work at the Torlak Institute of Virology in Belgrade, Serbia, on Tuesday, March 3, 2020. Coronavirus death rates, estimated at around 2%, are higher than the 0.1% for seasonal flu, another lung infection, but far lower than those from severe acute respiratory syndrome, or SARS, the related virus that killed about 9.6% of some 8,000 people infected. Photographer: Oliver Bunic/Bloomberg via Getty Images
Virus Research At Serbia's Institute of Virology
購買授權
我可如何使用此圖片？
HK$3,500.00
HKD

詳情

限制條件：
關於所有商業或推廣用途，請聯絡您當地辦公室的業務代表。For editorial use only. Additional clearance required for commercial or promotional use, contact your local office for assistance. Any commercial or promotional use of Bloomberg content requires Bloomberg's prior written consent.
來源:
Bloomberg / Contributor
編輯性內容編號：
1205043881
圖像集:
Bloomberg
建立日期：
2020年03月04日
上傳日期：
授權類型：
權利管理
發佈資訊:
無許可授權 更多資料
來源：
Bloomberg
物件名稱：
SERBIA VACCINE
最大檔案大小：
4000 x 2889 像素 (33.87 x 24.46 cm) - 300 dpi - 2 MB